...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith Epigenetics did not respond to invitatations in this one

Sorry there seem to have been some pasting issues, but scroll down to the last line. Zenith did not respond. Wondering why.

Share
New Message
Please login to post a reply